Deaths overshadow ocrelizumab trials in MS

Discuss Ocrelizumab, a monoclonal antibody treatment for MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Deaths overshadow ocrelizumab trials in MS

Post by MSUK » Thu May 20, 2010 9:08 pm

Image

Swiss drugmaker Roche AG and Biogen Idec Inc. are discontinuing development of ocrelizumab in patients with rheumatoid arthritis (RA), after an infection-related safety signal was observed in Phase III testing, resulting in the death of some patients.

Results from the program will be made... http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1397
MS-UK - http://www.ms-uk.org/

User avatar
HarryZ
Family Elder
Posts: 2570
Joined: Tue May 25, 2004 2:00 pm
Location: London, ON, Canada
Contact:

Re: Deaths overshadow ocrelizumab trials in MS

Post by HarryZ » Fri May 21, 2010 5:54 am

squiffy2 wrote:Image

Swiss drugmaker Roche AG and Biogen Idec Inc. are discontinuing development of ocrelizumab in patients with rheumatoid arthritis (RA), after an infection-related safety signal was observed in Phase III testing, resulting in the death of some patients.

Results from the program will be made... http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1397
Monoclonal antibodies...powerful and dangerous drugs to say the least.

Interesting to see that they have abandoned the trials of ocrelizumab for RA but are continuing the trials for MS patients!

Harry

Anunymouse
Family Member
Posts: 75
Joined: Thu Sep 04, 2014 10:07 pm

Re: Deaths overshadow ocrelizumab trials in MS

Post by Anunymouse » Wed Oct 18, 2017 5:57 am

Not really. There is always a risk/reward assessment in meds. MS patients tend to accept a much higher risk level than some other diseases.

User avatar
HarryZ
Family Elder
Posts: 2570
Joined: Tue May 25, 2004 2:00 pm
Location: London, ON, Canada
Contact:

Re: Deaths overshadow ocrelizumab trials in MS

Post by HarryZ » Wed Oct 18, 2017 7:06 am

Anunymouse wrote:Not really. There is always a risk/reward assessment in meds. MS patients tend to accept a much higher risk level than some other diseases.
Unfortunately they do because to date, there certainly isn't any cure and the current meds are not all that effective. This increases the frustration level of MS patients and likely why they are willing to take the additional risk.

Pesho
Family Member
Posts: 93
Joined: Thu Feb 23, 2012 1:39 pm

Re: Deaths overshadow ocrelizumab trials in MS

Post by Pesho » Wed Oct 18, 2017 11:09 am

From what I talked with my Neurologists doses for RA are much higher than for MS. There were deaths in the MS Trial Opera but they were few and it did not stop it. Anyway, not the best option but for now it keeps me kicking.

Post Reply
  • Similar Topics
    Replies
    Views
    Last post